A test of organic compounds in exhaled breath can help distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show. The results also reveal that the test can also define the stage of any cancer present.
"This could totally revolutionize lung cancer screening and diagnosis. The perspective here is the ...
A test of organic compounds in exhaled breath can help distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show. The results also reveal that the test can also define the stage of any cancer present.
"This could totally revolutionize lung cancer screening and diagnosis. The perspective here is the ...